An LSTM-based Approach Towards Automated Meal Detection from Continuous Glucose Monitoring in Type 1 Diabetes Mellitus | IEEE Conference Publication | IEEE Xplore
Type 1 Diabetes Mellitus (T1DM) is a metabolic disorder that results from a chronic autoimmune destruction of the insulin-producing pancreatic beta cells, and is characterized by elevated blood glucose levels. Long-term hyperglycaemia due to the absence of insulin secretion is associated with the onset of macrovascular (coronary artery disease, peripheral arterial disease, and stroke) and microvascular (diabetic nephropathy, neuropathy, and retinopathy) complications [1]. The injurious effects of hyperglycaemia can be prevented through optimal glycaemic control, which involves regular glucose measurements and exogenous insulin administration [2]. Technological advances in glucose sensors and insulin pumps, along with algorithmic progress towards the automated estimation of appropriate insulin infusion rates, have brought forward the development of wearable Artificial Pancreas (AP), with the ultimate goal to enable effective T1DM management [3]. Despite the promising performance of clos
Type 1 Diabetes Mellitus (T1DM) is a metabolic disorder that results from a chronic autoimmune destruction of the insulin-producing pancreatic beta cells, and is characterized by elevated blood glucose levels. Long-term hyperglycaemia due to the absence of insulin secretion is associated with the onset of macrovascular (coronary artery disease, peripheral arterial disease, and stroke) and microvascular (diabetic nephropathy, neuropathy, and retinopathy) complications [1]. The injurious effects of hyperglycaemia can be prevented through optimal glycaemic control, which involves regular glucose
Explore this link on the map →related reading
- Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes - PubMedpubmed.ncbi.nlm.nih.gov
- Can continuous glucose monitors benefit people without diabetes? - Breakthrough T1Dbreakthrought1d.org
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Gap Mapgap-map.org
- A Potential Dramatic Change in Treating Type 1 Diabetes - Jacobs School of Medicine and Biomedical Sciences - University at Buffalomedicine.buffalo.edu
- Sanofi Tzield: The 200 Best Inventions of 2023 | TIMEtime.com
- American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | American Society of Anesthesiologists (ASA)asahq.org
- Biolinq Shine™ Granted De Novo Classification by U.S. FDAglobenewswire.com
- Understanding LSTM Networks -- colah's blogcolah.github.io
- Six ways metabolic health affects longevity | Levels | Levelslevelshealth.com
- Four grams of glucose - PMCncbi.nlm.nih.gov
- Is blood sugar monitoring without diabetes worthwhile? - Harvard Healthhealth.harvard.edu